HopeStage
Back to all studies
Not Yet RecruitingNCT06228391

Ketamine versus midazolam for PTSD or depression after brain injury in veterans

About this titleRead the official source — NCT06228391
Medication studyAges 18–75United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: March 2024
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
40
Sponsor
Minneapolis Veterans Affairs Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT06228391
Official title
Show the full official title

Examining the Efficacy and Safety of Subanesthetic Ketamine on Depression and Post-traumatic Stress Among Veterans With Mild and Moderate Traumatic Brain Injury

Recruitment & locations

Not yet recruiting

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Minneapolis Veterans Affairs Medical Center, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including IV ketamine and Midazolam.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies